Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Arnaud Bourdin, Carey Suehs, Jérémy Charriot. Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship. Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019

Member's Comments

No comment yet.

Related content which might interest you: Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020 Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010 Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology Source: Eur Respir J 2001; 18: 246 Year: 2001 Patterns of adherence to inhaled corticosteroids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Oral vs. inhaled antibiotic therapy Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Budesonide/formoterol reduces the use of oral corticosteroids in the treatment of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007 The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Asthma control in general practice with inhaled corticosteroids and long-acting B2-agonists administered as a fixed or free combination at stable dosage: the ALISE survey Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Incidence of oropharyngeal candidiasis during treatment with high doses of inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 Switching asthma patients using high-dose inhaled steroids to budesonide/formoterol maintenance and reliever therapy Source: Annual Congress 2010 - Management of airway disease Year: 2010 Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006